An increase in ALDH (aldehyde dehydrogenase) activity, a marker for cancer progenitors, was observed in erlotinib-resistant lung cancer cells that displayed integrin β3+ compared to those cells that did not express integrin β3+, suggesting a contributing role of β3+ to the cancer stem cell phenotype [104]. This evidence concerns the gene IGKV4-1 and cancer.